Effect of Time of Menstrual Cycle on Drug Pharmacokinetics and Pharmacodynamics

Abstract

Gender has been shown to influence a number of pharmacokinetic variables including, serum protein binding (1), absorption rate (2), peak plasma concentration and area under the curve (3), and drug clearance (4) - A number of factors may contribute to gender differences in drug disposition including, differences in body composition, the use of oral contraceptives, plasma levels of the sex hormones, and the phases of the menstrual cycle (5,6). To date very few studies have actually examined the effects of the time of the menstrual cycle (follicular, ovulatory, luteal) on the pharmacokinetics and concomitant pharmacodynamics of a drug.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2001
Accession Number
ADA409105

Entities

People

  • Gary H. Kamimori

Organizations

  • Walter Reed Army Institute of Research

Tags

DTIC Thesaurus Topics

  • Blood Flow
  • Blood Proteins
  • Blood Volume
  • Cardiovascular Physiological Phenomena
  • Chemistry
  • Fatty Acids
  • Health Services
  • Heart Rate
  • Kinetics
  • Liquid Chromatography
  • Materials
  • Measurement
  • Menstrual Cycle
  • Pharmacokinetics
  • Reaction Time
  • Statistical Analysis
  • Test Methods

Fields of Study

  • Biology
  • Chemistry
  • Medicine

Readers

  • Toxicology/Environmental Toxicology
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.